Biocon Statistics

Total Valuation

Biocon has a market cap or net worth of INR 402.07 billion. The enterprise value is 600.54 billion.

Market Cap	402.07B
Enterprise Value	600.54B

Important Dates

The next estimated earnings date is Wednesday, January 29, 2025.

Earnings Date	Jan 29, 2025
Ex-Dividend Date	Jul 5, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	+2.80%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	443.97M

Valuation Ratios

The trailing PE ratio is 27.94.

PE Ratio	27.94
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.73, with an EV/FCF ratio of 25.03.

EV / Earnings	41.73
EV / Sales	4.03
EV / EBITDA	18.73
EV / EBIT	38.52
EV / FCF	25.03

Financial Position

The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.63.

Current Ratio	0.96
Quick Ratio	0.59
Debt / Equity	0.63
Debt / EBITDA	5.19
Debt / FCF	6.99
Interest Coverage	1.66

Financial Efficiency

Return on equity (ROE) is 7.31% and return on invested capital (ROIC) is 2.30%.

Return on Equity (ROE)	7.31%
Return on Assets (ROA)	1.77%
Return on Capital (ROIC)	2.30%
Revenue Per Employee	9.13M
Profits Per Employee	882,133
Employee Count	16,315
Asset Turnover	0.27
Inventory Turnover	1.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +33.13% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+33.13%
50-Day Moving Average	342.56
200-Day Moving Average	329.41
Relative Strength Index (RSI)	39.03
Average Volume (20 Days)	120,468

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biocon had revenue of INR 148.94 billion and earned 14.39 billion in profits. Earnings per share was 12.00.

Revenue	148.94B
Gross Profit	92.83B
Operating Income	15.86B
Pretax Income	23.71B
Net Income	14.39B
EBITDA	31.86B
EBIT	15.86B
Earnings Per Share (EPS)	12.00

Full Income Statement

Balance Sheet

The company has 26.50 billion in cash and 167.71 billion in debt, giving a net cash position of -141.21 billion.

Cash & Cash Equivalents	26.50B
Total Debt	167.71B
Net Cash	-141.21B
Net Cash Per Share	n/a
Equity (Book Value)	267.20B
Book Value Per Share	170.57
Working Capital	-6.52B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 40.37 billion and capital expenditures -16.37 billion, giving a free cash flow of 24.00 billion.

Operating Cash Flow	40.37B
Capital Expenditures	-16.37B
Free Cash Flow	24.00B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 62.33%, with operating and profit margins of 10.65% and 9.66%.

Gross Margin	62.33%
Operating Margin	10.65%
Pretax Margin	15.92%
Profit Margin	9.66%
EBITDA Margin	21.39%
EBIT Margin	10.65%
FCF Margin	16.11%

Dividends & Yields

Biocon does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-66.67%
Years of Dividend Growth	1
Payout Ratio	5.76%
Buyback Yield	-0.28%
Shareholder Yield	-0.28%
Earnings Yield	3.57%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on June 12, 2019. It was a forward split with a ratio of 2.

Last Split Date	Jun 12, 2019
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a